Effect of conjugated linoleic acid type, treatment period, and dosage on differentiation of 3T3 cells.
This study was conducted to determine effect of CLA and linoleic acid (LA) on cell differentiation, cellular glycerol-3-phosphate dehydrogenase (GPDH) activity, and FA accumulation in differentiating 3T3-L1 cells (3 isomers x 3 treatment periods x 4 doses). The cells were cultured in 24-well plates for proliferation until confluence. Then they were treated with media containing 0, 10, 35, or 70 mg/L (0, 35, 125, or 250 mmol/L, respectively) of LA, cis9,trans11- or trans10,cis12-CLA during early (day 0-2), intermediate and late (day 3-8), or overall (day 0-8) differentiation periods. Dexamethasone, methyl-isobutylxanthine, and insulin were supplemented to the media only for the early period to induce the differentiation. On day 8 of postconfluence the cells were harvested for Oil Red O staining, analysis of GPDH activity, and determination of the FA Concentration. Cellular LA or CLA was found to accumulate in a dose-response manner, mainly during the intermediate/late period. Treatment with trans10,cis12-CLA lowered (P < 0.05) GPDH activity and the concentration of FA including palmitic acid (16:0) and palmitoleic acid (16:1), especially during the intermediate/late and overall periods, or whenever a high dose of 70 mg/L was applied. This also resulted in a higher (P < 0.05) ratio of saturated FA to monounsaturated FA. Treatment with LA or cis9,trans11-CLA lowered cellular FA only when they applied during the early period at a dose of 70 mg/L. The results demonstrated that the inhibitory effects of CLA on differentiation, GPDH activity, and FA accumulation of 3T3-L1 cells are dependent on the isomer type, treatment period, and dose.
He
M L
ML
Department of Animal Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan. moro_he@yahoo.com
Hnin
T M
TM
Kuwayama
H
H
Mir
P S
PS
Okine
E K
EK
Hidari
H
H
D016475:3T3 Cells; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005227:Fatty Acids / Q000032:analysis; D005993:Glycerolphosphate Dehydrogenase / Q000378:metabolism; D019787:Linoleic Acid / Q000494:pharmacology; D044243:Linoleic Acids, Conjugated / Q000494:pharmacology*; D051379:Mice; D013997:Time Factors
D005227:Fatty Acids; D044243:Linoleic Acids, Conjugated; D019787:Linoleic Acid; D005993:Glycerolphosphate Dehydrogenase